XVIVO Heart Transplant Study in Clinical Practice
Recruiting
N/A
Interventional Study
Heart Failure
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 20 (estimated)
- Sponsor
- XVIVO Perfusion · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
HOPE for All is a clinical investigation to support the use of hypothermic oxygenated perfusion (HOPE) using a revised XVIVO Heart Assist Transport System in a real- world setting.
The trial will investigate the application of HOPE in a broad population of Donation after Brain Death (DBD) and Donation after Circulatory Death (DCD) donor hearts transplanted to any listed adult patient.
The hypoth…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria Recipient:
1. Age ≥18 years
2. Signed informed consent form
3. Accepted or listed for heart transplantation
Inclusion Criteria Heart Donor:
1. Accepted as a heart donor by the transplant team based on current standard of care criteria
2. DBD or DCD Maastricht category III or eu…
Contacts